These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 27320762)

  • 1. A Patient With Pancytopenia, Intractable Epistaxis, and Metastatic Prostate Cancer: How Correct Diagnosis of Primary Hyperfibrinolysis Helps to Stop the Bleeding.
    Jafri MA; Cohen JV; Much MA; Petrylak DP; Podoltsev NA
    Clin Genitourin Cancer; 2016 Oct; 14(5):e545-e548. PubMed ID: 27320762
    [No Abstract]   [Full Text] [Related]  

  • 2. Exceptional Response to Pembrolizumab in a Patient With Castration-Resistant Prostate Cancer With Pancytopenia From Myelophthisis.
    Vlachostergios PJ; Geyer JT; Miller J; Kosloff R; Beltran H; Tagawa ST
    J Oncol Pract; 2019 Jun; 15(6):343-345. PubMed ID: 30964731
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrent epistaxis as a presenting sign of androgen-sensitive metastatic prostate cancer.
    Lim HY; Agarwal AM; Agarwal N; Ward JH
    Singapore Med J; 2009 May; 50(5):e178-80. PubMed ID: 19495504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent epistaxis, chronic pancytopenia and nasal mycosis.
    Baumgart K; Motum P; Benson W
    Pathology; 1990 Apr; 22(2):111-4. PubMed ID: 2122399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated intravascular coagulation in a patient with metastatic prostate cancer: fatal outcome following strontium-89 therapy.
    Leong C; McKenzie MR; Coupland DB; Gascoyne RD
    J Nucl Med; 1994 Oct; 35(10):1662-4. PubMed ID: 7931669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case 28-2018: A 39-Year-Old Man with Epistaxis, Pain and Erythema of the Forearm, and Pancytopenia.
    Iyasere CA; Takvorian RW; Simeone FJ; Siegele BJ
    N Engl J Med; 2018 Sep; 379(11):1072-1081. PubMed ID: 30207921
    [No Abstract]   [Full Text] [Related]  

  • 7. Case report: Disseminated intravascular coagulation as the presenting sign of metastatic prostate cancer.
    Hicks J
    J Gen Intern Med; 2007 Jul; 22(7):1062. PubMed ID: 17458572
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic lupus erythematosus presenting with pancytopenia due to bone marrow myelofibrosis in a 22-year-old male.
    Aziz AR; Mohammadian Y; Ruby C; Momin Z; Kumar A; Griciene P; Gintautas J
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):467-9; discussion 469-70. PubMed ID: 16163223
    [No Abstract]   [Full Text] [Related]  

  • 9. Disseminated intravascular coagulation with excessive fibrinolysis in prostate cancer: a case series and review of the literature.
    Hyman DM; Soff GA; Kampel LJ
    Oncology; 2011; 81(2):119-25. PubMed ID: 21986538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multitargeted Treatment Approach for Anemia and Cachexia in Metastatic Castration-Resistant Prostate Cancer.
    Macciò A; Gramignano G; Madeddu C
    J Pain Symptom Manage; 2015 Aug; 50(2):e1-4. PubMed ID: 26004402
    [No Abstract]   [Full Text] [Related]  

  • 11. Resolution of thrombocytopenia secondary to disseminated intravascular coagulation with docetaxel chemotherapy in prostate cancer.
    Talebi TN; Manoharan M; Singal R
    Am J Ther; 2012 Jan; 19(1):e59-61. PubMed ID: 20535002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counterpoints: Which should be used first in symptomatic metastatic castration-resistant prostate cancer, docetaxel or radium? Docetaxel still the optimal first choice for symptomatic metastatic castration-resistant prostate cancer.
    Dreicer R
    Clin Adv Hematol Oncol; 2015 May; 13(5):293-5. PubMed ID: 26352772
    [No Abstract]   [Full Text] [Related]  

  • 13. [Massive bleeding due to primary fibrinolysis following rhinoplasty].
    Seligsohn U; Man AL
    Harefuah; 1972 Mar; 82(5):219-20. PubMed ID: 5052205
    [No Abstract]   [Full Text] [Related]  

  • 14. Disseminated intravascular coagulation as the presenting sign of metastatic prostate cancer.
    Duran I; Tannock IF
    J Gen Intern Med; 2006 Nov; 21(11):C6-8. PubMed ID: 17026724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epistaxis caused by an acquired thrombocytopathy].
    Veldhuizen JA; de Wolf JT; Buiter CT; Cats H
    Ned Tijdschr Geneeskd; 1989 Mar; 133(12):622-4. PubMed ID: 2716879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On hyperfibrinolysis and its treatment.
    Marx R; Meisner A
    Angiologica; 1968; 5(2):105-18. PubMed ID: 4232513
    [No Abstract]   [Full Text] [Related]  

  • 17. [HYPERFIBRINOLYSIS AND BENIGN HEMORRHAGIC MANIFESTATIONS].
    RAICHS A; SANCHEZ AGREDA M
    Sangre (Barc); 1964; 17():331-3. PubMed ID: 14218373
    [No Abstract]   [Full Text] [Related]  

  • 18. [Disseminated intravascular coagulation--pathophysiology].
    Matsuda T
    Nihon Rinsho; 1993 Jan; 51(1):15-20. PubMed ID: 8433509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of disseminated intravascular coagulation caused by Brucella melitensis.
    Turunc T; Demiroglu YZ; Kizilkilic E; Aliskan H; Boga C; Arslan H
    J Thromb Thrombolysis; 2008 Aug; 26(1):71-3. PubMed ID: 17562127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disseminated intravascular coagulation syndrome with secondary fibrinolysis activation in prostatic carcinoma].
    Iwan-Zietek I; Zietek Z; Kotschy M; Tyloch F; Szymański A
    Pol Tyg Lek; 1996 Feb; 51(6-9):100-1. PubMed ID: 8756745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.